Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: To investigate the relative pathogenicity of Candida albicans treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis. Previous studies indicate that these cells secrete 10 times more farnesol than do untreated cells. In our usage, subinhibitory means a concentration which causes a prominent decrease in turbidity but still allows some cell growth. METHODS: C. albicans A72 cells were grown overnight in 0-5.0 microM fluconazole, washed, and inoculated in mice by tail vein injection. Groups of 15 or 16 mice were injected with 1.3 x 10(6) cells and mortality was recorded for 7 days post-inoculation. The levels of farnesol in control and treated C. albicans were determined by GC/MS. RESULTS: The MIC50 for strain A72 was 0.125 mg/L (0.4 microM). Mice administered C. albicans pre-treated with 0.5 to 1.0 microM fluconazole died 2.5 to 4 days earlier and had 2 to 4 times higher mortality rates than mice given untreated C. albicans. Fluconazole (0.5 to 1.0 microM) pre-treated cells were 4.2 to 8.5 times more lethal (P < 0.001) than untreated cells. The extracellular, membrane bound, and intracellular farnesol concentrations of cells pre-treated with 1.0 muM fluconazole were 12-, 2- and 6-times those of untreated cells. CONCLUSIONS: The effects of fluconazole on C. albicans are very concentration-dependent. The enhanced pathogenicity of fluconazole pre-treated C. albicans in mice should be relevant to the therapeutic and prophylactic use of fluconazole. Further research is needed to explore whether farnesol production by C. albicans is a virulence factor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quorum Sensing in the Dimorphic Fungus Candida albicans Is Mediated by Farnesol
Hornby, J. M., Jensen, E. C., Lisec, A. D., Tasto, J. J., Jahnke, B., Shoemaker, R., Dussault, P., & Nickerson, K. W. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.7.2982-2992.2001 · Cited by 983
Self-citationHornby, J. M., Kebaara, B. W., & Nickerson, K. W. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2366-2369.2003 · Cited by 118 · cited 1×
“albicans synthesizes farnesol from farnesyl pyrophosphate (FPP).(7) Because FPP is the biosynthetic precursor of both farnesol(7) and ergosterol,(5) we hypothesized that drugs blocking the sterol biosynthetic pathway after FPP might lead to the accumulation of FPP, which, in turn, could”
Self-citationEstimating the Cost of Nosocomial Candidemia in the United States
Miller, L. G., Hajjeh, R. A., & Edwards, J. E. (2001) · Clinical Infectious Diseases · doi:10.1086/319613 · Cited by 109
Cited by
Quorum Sensing in Dimorphic Fungi: Farnesol and Beyond
Nickerson, K. W., Atkin, A. L., & Hornby, J. M. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.02765-05 · Cited by 290
Self-citationTalking to Themselves: Autoregulation and Quorum Sensing in Fungi
Hogan, D. A. (2006) · Eukaryotic Cell · doi:10.1128/ec.5.4.613-619.2006 · Cited by 262
The metabolic basis of Candida albicans morphogenesis and quorum sensing.
Han, T.-L., Cannon, R. D., & Villas-Bôas, S. G. (2011) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2011.04.002 · Cited by 173
“…the yeast-to-filamentous transition at high cell density, as well as under other hyphal-inducing conditions (e.g. serum, proline, and N-acetylglucosamine) (Hornby et al., 2001); but it is incapable of stopping the elongation of pre-existing hyphae (Mosel et al., 2005; Navarathna et al., 2005).”
Tashiro, M., Kimura, S., Tateda, K., Saga, T., Ohno, A., Ishii, Y., Izumikawa, K., Tashiro, T., Kohno, S., & Yamaguchi, K. (2012) · Medical Mycology · doi:10.3109/13693786.2011.610037 · Cited by 36
Arana, D. M., Nombela, C., & Pla, J. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp407 · Cited by 35
Metadata
- Authors
- Navarathna, D. H. M. L. P., Hornby, J. M., Hoerrmann, N., Parkhurst, A. M., Duhamel, G. E., & Nickerson, K. W.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-10-20
- Volume
- 56
- Issue
- 6
- Pages
- 1156-1159
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2106499050
- Cited by
- 88
- References
- 3
- FWCI
- 3.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis. https://app.cochat.ai/papers/10.1093/jac/dki383
- The paper
- Navarathna, D. H. M. L. P., Hornby, J. M., Hoerrmann, N., Parkhurst, A. M., Duhamel, G. E., & Nickerson, K. W. (2005). Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dki383
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.